Intravitreal bevacizumab injection for central serous chorioretinopathy.
about
Anti-VEGF Therapy and the Retina: An UpdateAdvances in the treatment of central serous chorioretinopathySubthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathyIntravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results.[Therapy options for chronic central serous chorioretinopathy. Photodynamic therapy combined with bevacizumab - a case series].Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.Diagnosis and interventions for central serous chorioretinopathy: review and update.[Treatment of central serous chorioretinopathy: MicroPulse photocoagulation versus bevacizumab].Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathyCentral serous chorioretinopathy: update on pathophysiology and treatment.Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series.Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.The association between choroidal thickness variations and response to intravitreal bevacizumab in central serous chorioretinopathy.Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.Therapeutic benefit of melatonin in refractory central serous chorioretinopathyVariation in Visual Outcome to Anti-Vascular Endothelial Growth Factors in Choroidal Neovascular Membrane Developing in Eyes with Previously Untreated Versus Focal Laser-Treated Central Serous Chorioretinopathy.Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.Experience of intravitreal injections in a tertiary Hospital in Oman.Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.A case of idiopathic central serous chorioretinopathy in a 12-year-old male treated with bevacizumab.Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration.Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab.Effect of Intravitreal Injection of Bevacizumab on Acute Central Serous Chorioretinopathy Patients Who Visited Feiz Hospital during 2014-2015 Period.The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.Efficacy of oral rifampicin in chronic central serous chorioretinopathy
P2860
Q26784605-172CB6C1-1F7B-4A3B-AF4D-255D0BA67B9FQ28088443-99799374-1E91-4860-A050-CA586F3C04B6Q31040895-1DC667D1-BAC0-4457-80B8-B7F6E2ABDD97Q33996055-70C613AC-DF7B-4C7C-8908-E52C407CDD7AQ34076295-3ECF1660-98D3-48C4-881E-86CBB5216424Q34210541-FA83B6E4-BFBC-4755-82BD-5789B019F11BQ34334335-D3BF27B7-574A-4297-911D-46F92A08217EQ34439977-449EF030-BCF0-4FAA-BE52-499C671C1C76Q34447890-82E0EF4E-AB6D-42D7-A4D8-E5E9951C00A7Q34587658-8C589070-8816-409D-BF2F-200FAF4F7570Q35176611-5BBBEA9B-D777-4465-886F-2E7A1F670053Q35567966-4B19A68B-79CD-454E-81BC-65781ABD3BBDQ35657257-7C599FC9-76BA-44BE-A9A4-C0F227A56EF3Q35749002-F21F4A25-6E2E-4440-B4EC-DD5C40C1DA3EQ35970032-D4B48A90-563E-4A79-94C2-4C608FB6616FQ36106039-C344C20D-0D38-4050-B98D-B9AE37FCC744Q36339246-36A799CF-BAFA-4692-B43D-391A0D3E7FC0Q36685488-2464C576-6B5C-435E-8332-16C8CC9F12FEQ38160720-3D03B510-F5FB-4E68-8B61-D8AAEED362B6Q38745804-9878F1D0-8A4A-4540-9469-F84B52F5218BQ41190093-A2B99AAE-0F51-47BA-B1D8-A0914AD4F9A9Q42047268-8F26D72A-ED69-4264-86CE-6D022E6DAA01Q42566790-5B1C2A69-ABD7-459B-A407-5B5F66249F3EQ43718620-F0C9FD05-CB3F-420D-B13E-4746CD040022Q47104800-704CCEC2-A709-4BFA-A1CA-BF0AE3352060Q50531998-4A3DC7A1-8984-4330-86DA-AEF471C93B26Q50544506-13711EE2-D451-4780-A5B1-C0F358313364Q54942391-AB0ED268-95FF-409D-8472-77A31E520DAFQ57814622-DF2308FB-823D-4172-91A4-828B0A7D3893
P2860
Intravitreal bevacizumab injection for central serous chorioretinopathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Intravitreal bevacizumab injection for central serous chorioretinopathy.
@en
Intravitreal bevacizumab injection for central serous chorioretinopathy.
@nl
type
label
Intravitreal bevacizumab injection for central serous chorioretinopathy.
@en
Intravitreal bevacizumab injection for central serous chorioretinopathy.
@nl
prefLabel
Intravitreal bevacizumab injection for central serous chorioretinopathy.
@en
Intravitreal bevacizumab injection for central serous chorioretinopathy.
@nl
P1433
P1476
Intravitreal bevacizumab injection for central serous chorioretinopathy
@en
P2093
Oh Woong Kwon
Su Jin Lim
P304
P356
10.1097/IAE.0B013E3181BCF0B4
P50
P577
2010-01-01T00:00:00Z